The analysis of estrogen receptor α (ER-α) gene Pvull and Xbal polymorphisms in postmenopausal women with breast cancer;Analiza polimorfizmów Pvull i Xbal genu receptora estrogenowego α (ER-α) u kobiet chorych na raka piersi w wieku pomenopauzalnym

Polski Merkuriusz Lekarski

Volumn 25, Issue 145, 2008, Pages 43-45

  Sobczuk, Anna ^a   Pertynski, Tomasz ^a   Smolarz, Beata ^a   Romanowicz Makowska, Hanna ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Breast cancer; Estrogen receptor; Gene polymorphism; PCR RFLP

Indexed keywords

ESR1 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA;

AGED; ARTICLE; BREAST TUMOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MIDDLE AGED; POSTMENOPAUSE;

AGED; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE;

EID: 49949112621     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Andersen T.I., Heimdal K.R., Skrede M. i wsp.: Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum. Genet., 1994, 94, 665-670.
2. Beato M., Herrlich P., Schultz G.: Steroid hormone receptors: many actors in search of a plot. Cell, 1995, 83, 851-857.
3. Boyapati S.M., Ou Shu X., Ruan Z.X. i wsp.: Polymorphism in ER gene interact with estrogen receptor status in breast cancer survival. Clinical Cancer Res., 2005, 11, 1093-1098.
4. Cai Q., Gao Y.T., Wen W.: Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor alpha gene. Cancer Res., 2003, 63, 5727-5730.
5. Cai Q., Shu X.O., Jin F.: Genetic polymorphism in the estrogen receptor alpha gene and risk of breast cancer results from the Shanghai Breast Cancer Study. Cancer Epidemiol. Biomarkers Prev., 2003, 12, 853-859.
6. Cauley J.A., Lucas F.L., Kuller L.H. i wsp.: Bone mineral density and risk of breast cancer in older women. The study of osteoporotic fractures. J. Am. Med. Assoc., 1996, 276, 1404-1408.
7. Clark J.H., Shrader W.T., O'Malley B.M.: Mechanisms of action of steroid hormones. In: Textbook of Endocrinology. Wilson J.D. and Foster D.W. (red.). New York, NY: W.B. Saunders Co., 1992, 35-90.
8. Douchi T., Yonehara Y, Kosha S. i wsp.: Bone mineral density in breast cancer patients with positive estrogen receptor tumor status. Maturitas 2007, 18 (epub ahead of print).
9. Gennari L., Becherini L., Masi L. i wsp.: Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J. Clin. Endocrinol. Metab., 1998, 83, 939-944.
10. Man K.O., Moon I.G., Kang Y.S. i wsp.: Association of estrogen receptor genotypes with the mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J. Clin. Endocrinol. Metab., 1997, 82, 991-995.
11. Hankinson S.E., Willett W.C., Manson J.E.: Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst., 1998, 90, 1292-1299.
12. Herrington D.M., Howard T.D., Hawkins G.A.: Estrogen receptor polymorphism and effects of estrogen replacement on high density lipoprotein cholesterol in women with coronary disease. N. Engl. J. Med., 2002, 346, 967-974.
13. Hortobagyi G.N.: Treatment of breast cancer. New Engl. J. Med., 1998, 339, 974-984.
14. Hu Z., Song C.G., Lu J.S. i wsp.: A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives. J. Cancer Res. Clin. Oncol., 2007, 12 [epub ahead of print].
15. Jensen E.V., Jordan V.C.: The estrogen receptor: a model for molecular medicine. Clinical Cancer Res., 2003, 9, 1980-1989.
16. Kan Y.W., Dozy A.M.: Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc. Natl. Acad. Sci. USA, 1978, 75, 5631-5635.
17. Kobayashi N., Fujino T., Shirogane T.: Estrogen receptora polymorphism as a genetic marker for bone loss, vertebral fractures, and susceptibility to estrogen. Maturitas, 2002, 41, 193-201.
18. Kobayashi S., Inoue S., Hosoi T. i wsp.: Association of bone mineral density with polymorphism of the estrogen receptor gene. J. Bone Miner. Res. 1996, 11, 306-311.
19. McGuire W.L., Chamness G.G., Fuqua S.A.W.: Abnormal estrogen receptor in clinical breast cancer. J. Steroid Biochem. Mol. Biol., 1992, 43, 243-247.
20. Mizunuma H., Hosoi T., Okano H. i wsp.: Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone, 1997, 21, 379-383.
21. Murphy L., Cherlet T., Lewis A. i wsp.: New insights into estrogen receptor function in human breast cancer. Ann Med., 2003, 35, 614-631.
22. Ongphiphadhanakul B., Rajatanavin R., Chanprasertyothin S. i wsp.: Estrogen receptor gene polymorphism is associated with bone mineral density in premenopausal women but not in postmenopausal women. J. Endocrinol. Invest., 1998, 21, 487-493.
23. Parl F.F., Cavener D.R., Dupont W.D.: Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res. Treat., 1989, 14, 57-64.
24. Roodi N., Bailey L.R., Kao W.Y. i wsp.: Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl. Cancer Inst. 1995, 87, 446-451.
25. Sano M., Inoue S., Hosoi T. i wsp.: Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem. Biophys. Res. Commun., 1995, 217, 378-383.
26. Shearman A.M., Cupples L.A., Demissie S.: Association between estrogen receptora gene variation and cardiovascular disease. JAMA, 2003, 290, 2263-2270.
27. Turner R.T., Riggs B.L., Spelsberg T.C.: Skeletal effects of estrogens. Endocr. Rev., 1994, 15, 275-300.
28. Weiderpass E., Persson I., Melhus H. i wsp.: Estrogen receptor gene polymorphisms and endometrial cancer risk. Carcinogenesis, 2000, 21, 623-627.
29. Willing M., Sowers M., Aron D. i wsp.: Bone mineral density and its change in white women: estrogen and vitamin D receptor gene genotypes and their interaction. J. Bone Miner. Res., 1998, 13, 695-705.
30. Yaich L., Dupont W.D., Cavener D.R. i wsp.: Analysis of the Pvu II restriction fragment-lengh polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res., 1992, 52, 77-83.
31. Zhang Y., Kiel D.P., Kreger B. E. i wsp.: Bone mass and the risk of breast cancer among postmenopausal women. N. Engl. J. Med., 1997, 336 611-617.